Related Experiment Video
Updated: Oct 23, 2026
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit
D C Bergmans1, M J Bonten, F H van Tiel
1Department of Internal Medicine, University Hospital Maastricht, The Netherlands.
Background:
Ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa is usually preceded by colonisation of the respiratory tract. During outbreaks, colonisation with P aeruginosa is mainly derived from exogenous sources. The relative importance of different pathways of colonisation of P aeruginosa has rarely been determined in non-epidemic settings.
Methods:
In order to determine the importance of exogenous colonisation, all isolates of P aeruginosa obtained by surveillance and clinical cultures from two identical intensive care units (ICUs) were genotyped with pulsed field gel electrophoresis.
Results:
A total of 100 patients were studied, 44 in ICU 1 and 56 in ICU 2. Twenty three patients were colonised with P aeruginosa, seven at the start of the study or on admission and 16 of the remaining 93 patients became colonised during the study. Eight patients developed VAP due to P aeruginosa. The incidence of respiratory tract colonisation and VAP with P aeruginosa in our ICU was similar to that before and after the study period, and therefore represents an endemic situation. Genotyping of 118 isolates yielded 11 strain types: eight in one patient each, two in three patients each, and one type in eight patients. Based on chronological evaluation and genotypical identity of isolates, eight cases of cross-colonisation were identified. Eight (50%) of 16 episodes of acquired colonisation and two (25%) of eight cases of VAP due to P aeruginosa seemed to be the result of cross-colonisation.
Conclusions:
Even in non-epidemic settings cross-colonisation seems to play an important part in the epidemiology of colonisation and infection with P aeruginosa.
Insights
Cross-colonisation by Pseudomonas aeruginosa is a significant factor in respiratory tract colonisation and ventilator-associated pneumonia (VAP) even in non-outbreak settings. This highlights the importance of infection control measures to prevent patient-to-patient transmission in intensive care units (ICUs).
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa often follows respiratory tract colonization.
- In outbreaks, P. aeruginosa colonization is typically exogenous, but its role in endemic settings is less understood.
Purpose of the Study:
- To determine the significance of exogenous sources in P. aeruginosa colonization and VAP in non-epidemic intensive care unit (ICU) settings.
- To evaluate the contribution of cross-colonization to the epidemiology of P. aeruginosa.
Main Methods:
- Genotyping of P. aeruginosa isolates from surveillance and clinical cultures in two ICUs using pulsed field gel electrophoresis.
- Chronological evaluation of genotypically identical isolates to identify cross-colonization events.
Main Results:
- 100 patients were studied; 23 became colonized with P. aeruginosa, and 8 developed VAP.
- Genotyping identified 11 P. aeruginosa strain types, with one type found in 8 patients.
- Eight cases of cross-colonization were identified, contributing to 50% of acquired colonizations and 25% of VAP cases.
Conclusions:
- Cross-colonization plays a substantial role in the epidemiology of P. aeruginosa colonization and VAP, even in endemic ICU settings.
- Findings underscore the need for vigilance and infection control strategies to mitigate transmission.
Related Concept Videos
01:25Colonisation of Pathogens
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...